Subject(s)
Edema/chemically induced , HIV Infections/drug therapy , HIV Protease Inhibitors/adverse effects , Pyrimidinones/adverse effects , Ritonavir/adverse effects , Adult , HIV Protease Inhibitors/administration & dosage , Humans , Lopinavir , Male , Pyrimidinones/administration & dosage , Recurrence , Ritonavir/administration & dosageSubject(s)
Humans , Male , Adult , Edema , HIV Infections , HIV Protease Inhibitors , Ritonavir , Hand , HIV Protease Inhibitors , Recurrence , RitonavirSubject(s)
Edema/chemically induced , HIV Infections/complications , HIV Protease Inhibitors/adverse effects , HIV-1 , Pyrimidinones/adverse effects , Adult , Antiretroviral Therapy, Highly Active , HIV Infections/drug therapy , HIV Infections/immunology , HIV Infections/physiopathology , HIV Protease Inhibitors/therapeutic use , Humans , Lopinavir , Male , Middle Aged , Pyrimidinones/therapeutic useABSTRACT
The development of paradoxical clinical worsening following initiation of tuberculosis treatment may complicate the clinical course of both HIV-infected and uninfected patients. We report a severe manifestation of the so called paradoxical reaction to the treatment of tuberculosis that unmasked previously silent meningeal disease in a 34-year-old HIV-infected male patient.
Subject(s)
Anti-HIV Agents/adverse effects , Antitubercular Agents/adverse effects , Tuberculosis, Meningeal/diagnosis , Adult , Drug Interactions , Humans , Male , Tuberculosis, Meningeal/etiologyABSTRACT
The development of paradoxical clinical worsening following initiation of tuberculosis treatment may complicate the clinical course of both HIV-infected and uninfected patients. We report a severe manifestation of the so called paradoxical reaction to the treatment of tuberculosis that unmasked previously silent meningeal disease in a 34-year-old HIV-infected male patient.